Clinical characteristics and economic costs of patients with painful neuropathic disorders
Ariel Berger(Policy Analysis (United States)), Gerry Oster(University of Washington Medical Center), Ellen Dukes(Pfizer (United States))
Cited by 351
Related Papers
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2006|1.3k
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
|CHEST Journal|2002|1.3k
Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation
|Journal of Clinical Oncology|2001|682
Lifetime Health and Economic Consequences of Obesity
|Archives of Internal Medicine|1999|461